Abstract
Pathogens have evolved diverse mechanisms for escaping host innate and adaptive immunity. Viruses that maintain a persistent infection are particularly effective at disabling key arms of the host immune response. For example, the herpesviruses establish a persistent infection in human and animal hosts, in part through critical immunoevasive strategies. Cytomegalovirus, a beta-herpesvirus, impairs major histocompatibility complex (MHC) class I and class II antigen presentation by decreasing MHC expression on the surface of the infected cell, thus enabling infected cells to escape CD8+ and CD4+ T lymphocyte immunosurveillance. Moreover, cytomegalovirus blocks the interferon signal transduction pathway, thereby limiting the direct and indirect antiviral effects of the interferons. In this review, we focus on an emerging paradigm in which the effectiveness of viruses, particularly human cytomegalovirus, to escape antiviral immune responses is significantly enhanced by their ability to inhibit MHC transcription and interferon (IFN)-stimulated (JAK/STAT) signal transduction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barnard P, McMillan NA (1999) The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-α. Virology 259:305–313
Biron CA (1994) Cytokines in the generation of immune responses to, and resolution of, virus infection Curr Opin Immunol 6:530–538
Boss JM (1997) Regulation of transcription of MHC class II genes. Curr Opin Immunol 9:107–113
Chen M, Shirai M, Liu Z, Arichi T, Takahashi H, Nishioka M (1998) Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4+ T cells. J Virol 72:8301–8308
Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE Jr, Kuriyan J (1998) Crystal structure of a tyrosine phosphorylated Stat-1 dimer bound to DNA. Cell 93:827–839
Darnell JE Jr (1997) STATs and gene regulation. Science 277:1630–1635
Darnell JE Jr, Kerr IM, Stark GR (1994) Jak-Stat pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415–1421
David M (1995) Transcription factors in interferon signaling. Pharmacol Ther 65:149–161
Davignon J-L, Castanie P, Yorke J A, Gautier N, Clement D, Davrinche C (1996) Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro. J Virol 70:2162–2169
Doherty P (1995) Immunity to viruses. The Immunologist 3:231–233
Durbin JE, Hackenmiller R, Simon MC, Levy DE (1996) Targeted disruption of the mouse STAT1 gene results in compromised innate immunity to viral disease. Cell 84:443–450
Fish KN, Stenglein SG, Ibanez C, Nelson J A (1995) Cytomegalovirus persistence in macrophages and endothelial cells. Scand J Infect Dis 99:34–40
Foster GR, Ackrill AM, Goldin RD, Kerr IM, Thomas HC, Stark GR (1991) Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double stranded RNA. Proc Natl Acad Sci USA 88:2888–2892
Ghislain JJ, Fish EN (1996) Application of genomic DNA affinity chromatography identifies multiple interferon-alpha-regulated Stat2 complexes. J Biol Chem 271:12408–12413
Girdlestone J (1996) Transcriptional regulation of MHC class I genes. Eur J Immunogenet 23:393–413
Glimcher LH, Kara CJ (1992) Sequences and factors: a guide to MHC class II transcription. Annu Rev Immunol 10:13–49
Gobin SJ, Peijnenburg A, Keijsers V, van den Elsen P (1997) Site α is crucial for two routes of IFNγ-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 6:601–611
Gobin SJ, van den Elsen PJ (1999) The regulation of HLA class I expression: is HLA-G the odd one out Semin Cancer Biol 9:55–59
Gribaudo G, Ravaglia S, Caliendo A, Cavallo R, Gariglio M, Martinotti MG, Landolfo S (1993) Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology 197:303–311
Haque SJ, Williams BRG (1994) Identification and characterization of an interferon (IFN)-stimulated response element-IFN-stimulated gene factor 3-independent signaling pathway for IFN-α. J Biol Chem 269:19523–19529
Harcourt BH, Sanchez A, Oiferman MK (1999) Ebola virus selectively inhibits responses to interferons but not to interleukin-1 α, in endothelial cells. J Virol 73:3491–3496
Heemels MT, Ploegh H (1995) Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev Biochem 64:463–491
Heise MT, Connick M, Virgin HW (1998) Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J Exp Med 187:1037–1046
Heise MT, Virgin HW (1995) The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J Virol 69:904–909
Hengel H, Eblinger C, Pool J, Goulmy E, Koszinowski UH (1995) Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol 76:2987–2997
Hengel H, Lucin P, Jonjic S, Ruppert T, Koszinowski UH (1994) Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J Virol 68:289–297
Hirsch MS, Schooley RT, Cosimi AB, Russell PS, Delmonico FL, TolkofT-Rubin NE, Herrin JT, Cantell K, Farrell ML, Rota TR, Rubin RH (1983) Effects of interferon-alpha on cytomegalo-virus reactivation syndromes in renal-transplant recipients. N Engl J Med 308:1489–1493
Hobart M, Ramassar V, Goes N, Urmson J, Halloran PF (1997) IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J Immunol 158:4260–4269
Isaacs A, Lindenmann J (1957) Virus interference. The interferons. Proc R Soc Lond B 147:258–267
Johnsen A, France J, Sy M-S, Harding CV (1998) Downregulation of the transporter for antigen presentation, proteasome subunits and class I MHC in tumor cell lines. Cancer Res 58:3660–3667
Jonjic S, Mutter W, Weiland F, Reddehase MJ, Koszinowski UH (1989) Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4 T lymphocytes. J Exp Med 169:1199–1212
Jonjic S, Pavic I, Lucin P, Rukavina D, Koszinowski UH (1990) Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. J Virol 64:5457–5464
Joseph J, Knobler RL, Eublin FD, Hart MN (1991) Mouse hepatitis virus (MHV-4. JHM) blocks gamma interferon-induced major histocompatibility complex class II antigen expression on murine cerebral endothelial cells. J Neuroimmunol 33:181–190
Kanda K, Decker T, Aman P, Wahlstrom M, von Gabain A, Kalian B (1992) The EBNA2- related resistance towards alpha interferon (IFN-α) in Burkitt’s lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF3. Mol Cell Biol 12:4930–4936
Kara CJ, Glimcher LH (1991) In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science 252:709–712
Kimura T, Kadokawa Y, Harada H, Matsumoto M, Sato M, Kashiwazaki Y, Tarutani M, Tan RS, Takasugi T, Matsuyama T, Mak TW, Noguchi S, Taniguchi T (1996) Essential and nonredundant roles of p48 (ISGF3-γ) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells 1:115–124
Kimura T, Nakayama K, Penninger J, Kitagawa M, Harada H, Matsuyama T. Tanaka K, Kamijo R, Vilcek J, Mak TW (1994) Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264:1921–1924
Knight DA, Waldman WJ, Sedmak DD (1997) Human cytomegalovirus does not induce human leukocyte antigen class II expression on arterial endothelial cells. Transplantation 63:1366–1369
Koffron AJ, Hummel M, Patterson BK, Yan S, Kaufman DB, Fryer JP, Stuart J, Stuart FP (1998) Cellular localization of latent murine cytomegalovirus. J Virol 72:95–103
Kootstra G, Hammerling GJ. Momburg F (1997) Generation, intracellular transport and loading of peptides associated with MHC class I molecules. Curr Opin Immunol 9:80–88
Koromilas AE, Roy S, Barber GN, Katze MG, Sonenberg N (1992) Malignant transformation by a mutant of the interferon-inducible dsRNA-dependent protein kinase. Science 257:1685–1689
Kotenko SV, Izotova LS, Pollack BP, Mariano TM, Donnelly RJ, Muthukumaran G, Cook JR, Garotta G, Silvennoinen 0, Ihle JN (1995) Interaction between the components of the interferon-γ receptor complex. J Biol Chem 270:20915–20921
Kwan WC, McMaster WR, Wong N, Reiner NE (1992) Inhibition of expression of major histocompatibility complex class II molecules in macrophages infected with Leishmania donovanioccurs at the level of gene transcription via a cyclic AMP-independent mechanism. Infect Immun 60:2115–2120
Le Roy E, Muhlethaler-Mottet A, Davrinche C, Mach B, Davignon J (1999) Escape of human cytomegalovirus from HLA-DR-restricted CD4+ T-cell response is mediated by repression of γ interferon-induced class II transactivator expression. J Virol 73:6582–6589
Lehtonen A, Matikainen S, Julkunen I (1997) Interferons upregulate Statl, Stat2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages. J Immunol 159:794–803
Leonard GT, Sen GC (1996) Effects of adenovirus El A protein on interferon-signaling. Virology 224:25–33
Leonard GT, Sen GC (1997) Restoration of interferon responses of adenovirus ElA-expressing HT1080 cell lines by overexpression of p48 protein. J Virol 71:5095–5101
Li X, Leung S, Kerr IM, Stark GR (1997) Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Mol Cell Biol 17:2048–2056
Li X, Leung S, Qureshi S, Darnell JE, Stark GR (1996) Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-α. J Biol Chem 271:790–794
Lu HT, Riley JL, Babcock GT, Huston M, Stark GR, Boss JM, Ransohoff RM (1995) Interferon (IFN) β acts downstream of IFN-γ-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-y. J Exp Med 182:1517–1525
Lucin P, Jonjic S, Messerle M, Polic B, Hengel H, Koszinowski UH (1994) Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J Gen Virol 75:101–110
Lucin P, Pavic I, Polic B, Jonjic S, Koszinowski UH (1992) Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J Virology 66:1977–1984
Martin BK, Chin KC, Olsen JC, Skinner CA, Dey A, Ozato K, Ting JP (1997) Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6:591–600
Martinotti MG, Gribaudo G, Gariglio M, Caliendo A, Lembo D, Angeretti A, Cavallo R, Landolfo S (1993) Effect of interferon-α on immediate early gene expression of murine cytomegalovirus. J Interferon Res 13:105–109
Meurs EF, Galabru J, Barber GN, Zatze MG, Hovanessian AG (1992) Tumor suppressor function of the interferon-induced double stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 90:232–236
Miller DM, Rahill BM, Boss JM, Laimore MD, Durbin JE, Waldman WJ, Sedmak DD (1998) Human cytomegalovirus inhibits MHC class II expression by disruption of the Jak/Stat pathway. J Exp Med 187:675–683
Miller DM, Zhang Y, Rahill BM, Kazor K, Rofagha S, Eckell JJ, Sedmak DD (2000) Human cytomegalovirus blocks interferon-γ stimulated up-regulation of major histocompatibility complex class I expression and the class I antigen processing machinery. Transplantation 69:687–690
Miller DM, Zhang Y, Rahill BM, Waldman WJ, Sedmak DD (1999) Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. J Immunol 162:6107–6113
Muhlethaler-Mottet A, Di Berardino W, Otten LA, Mach B (1998) Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Statl and USF-1. Immunity 8:157–166
Muller D, Koller BH, Whitton JL, LaPan KE, Brigman KK, Frelinger JA (1992) LCMV-specific, class II-restricted cytotoxic T cells in β-2 microglobulin deficient mice. Science 255:1576–1578
Muller M, Briscoe J, Laxton C, Guschin D, Ziemiecki A, Silvennoinen O, Harpur AG, Barbieri G, Witthuhn BA, Schindler C (1993) The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature 366:129–135
Orange JS, Wang B, Terhorst C, Biron CA (1995) Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 182:1045–1056
Ortiz BD, Nelson PJ, Krensky AM (1997) Switching gears during T-cell maturation: RANTES and late transcription. Immunol Today 18:468–471
Otten LA, Steimle V, Bontron S, Mach B (1998) Quantitative control of MHC class II expression by the transactivator CIITA. Eur J Immunol 28:473–478
Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Duersen JM, Grosveld G, Ihle JN (1998) Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93:385–395
Pollock JL, Presti RM, Paetzold S, Virgin HW (1997) Latent murine cytomegalovirus infection in macrophages. Virology 227:168–179
Presti RM, Pollock JL, Dal Canto AJ, O’Guin AK, Virgin HW (1998) Interferon-γ regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med 188:577–588
Ramassar V, Goes N, Hobart M, Halloran PF (1996) Evidence for the in vivo role of class II transactivator in basal and IFN-g induced class II expression in mouse tissue. Transplantation 62:1901–1907
Riley JL, Westerheide SD, Price JA. Brown JA, Boss JM. (1995) Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533–543
Samuel CE (1991) Antiviral actions of interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183:1–11
Schindler C, Darnell JE (1995) Transcriptional responses to polypeptide ligands: The jak-stat pathway. Annu Rev Biochem 64:621–651
Schindler C, Shuai K, Prezioso VR, Darnell JE (1992) Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257:809–813
Scholz M, Hamann A, Blaheta RA. Auth MK, Encke A, Markus BH (1992) Cytomegalovirus and interferon-related effects on human endothelial cells: cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-gamma. Hum Immunol 35: 230–238
Schut RL, Gekker G, Hu S, Chao CC, Pomeroy C, Jordan MC. Peterson PK (1994) Cytomegalovirus replication in murine microglial cell cultures: suppression of permissive infection by interferon-gamma. J Infect Dis 169:1092–1096
Sedmak DD, Chaiwiriyakul S, Knight DA. Waldman WJ (1995) The role of interferon β in cytomega-lovirus-mediated inhibition of HLA-DR induction. Arch Virol 140:111–126
Sedmak DD, Guglielmo AM, Knight DA. Birmingham DJ. Huang EH, Waldman WJ (1994) Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am J Pathol 144:683–692
Shirayoshi Y, Burke PA, Appella E, Ozato K (1988) Interferon induced transcription of a major histocompatibility class I gene accompanies binding of inducible nuclear factors to the interferon consensus sequence. Proc Natl Acad Sei USA 85:5884–5888
Silacci P, Mottet A, Steimle V, Reith W, Mach B (1994) Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J Exp Med 180:1329–1336
Steimle V, Otten LA, Zufferey M. Mach B (1993) Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135–146
Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B (1994) Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265:106–109
Takeda T, Nakajima K. Kojima H. Hirano T (1994) El A repression of IL-6-induced gene activation by blocking the assembly of IL-6 response element binding complexes. J Immunol 153:4573–4582
Ting JPY, Baldwin AS (1993) Regulation of MHC gene expression. Curr Opin Immunol 5:8–16
van den Elsen PJ, Gobin SJP. van Eggermond MCA. Peijnenburg A (1998) Regulation of MHC class I and II gene transcription: differences and similarities. Immunogenetics 48:208–221
Varga SM, Welsh RM (1998) Detection of a high frequency of virus-specific CD4 T cells during acute infection with lymphocytic choriomenigitis virus. J Immunol 161:3215–3218
Veals SA, Schindler C, Leonard D, Fu XY, Aebersold R, Darnell JE Jr, Levy DE (1992) Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol Cell Biol 12:3315–3324
Vilcek J, Sen GC (1996) Interferons and other cytokines. In: Fields BN. Knipe DM. Howley PM (eds) Fields Virology, 3rd Edition, Lippencott-Raven Publishers, Philadelphia
Vogel J, Kress M, Khoury G. Jay G (1986) A transcriptional enhancer and an interferon-rcsponsive sequence in major histocompatibility complex class I genes. Mol Cell Biol 6:3550–3554
Yeow W-S, Lawson CM, Beilharz MW (1998) Antiviral activities of individual murine IFN-(alpha) subtypes in vivo: intramuscular injection of I FN expression constructs reduces cytomegalovirus replication. J Immunol 160:2932–2939
Yokosawa N, Kubota T, Fujii N (1998) Poor induction of interferon-induced 2’,5’-oligoadenylate synthetase (2–5 AS) in cells persistently infected with mumps virus is caused by decrease of STAT-1α. Arch Virol 143:1985–1992
Zhong G, Fan T, Liu L (1999) Chlamydia inhibits interferon gamma-inducible major Histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J Exp Med 189: 1931–1938
Zhou H, Glimcher LH (1995) Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2: 545–553
Zhou H, Su H, Zhang X, Douhan J, Glimcher L (1997) CIITA-dependent and independent class II MHC expression revealed by a dominant negative mutant. J Immunol 158:4741–1749
Zhu H, Cong JP, Shenk T (1997) Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: Induction of interferon-responsive RNAs. Proc Natl Acad Sci USA 94:13985–13990
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Miller, D.M., Cebulla, C.M., Sedmak, D.D. (2002). Human Cytomegalovirus Inhibition of Major Histocompatibility Complex Transcription and Interferon Signal Transduction. In: Koszinowski, U.H., Hengel, H. (eds) Viral Proteins Counteracting Host Defenses. Current Topics in Microbiology and Immunology, vol 269. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59421-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-59421-2_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63974-6
Online ISBN: 978-3-642-59421-2
eBook Packages: Springer Book Archive